Before you sell to, join or invest in Sonnet BioTherapeutics Holdings, Inc.
MentionFox check on Sonnet BioTherapeutics Holdings, Inc.: only 1 source on file so far (checked 6 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/sonnet-biotherapeutics-holdings-inc-form-d-24000001
Check Sonnet BioTherapeutics Holdings, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about Sonnet BioTherapeutics Holdings, Inc.?
Sonnet BioTherapeutics Holdings, Inc. filed a Form D with the Securities and Exchange Commission on 2024-12-23.
Sonnet BioTherapeutics Holdings, Inc. filed a Form D notice of an exempt securities offering with the SEC on December 23, 2024. The filing reports $3.92M sold. Its industry group is Biotechnology. It names Pankaj Mohan (Executive Officer, Director), Jay Cross (Executive Officer), John Cini (Executive Officer) (SEC Form D, December 23, 2024).
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Is this your company?
Run the free check on Sonnet BioTherapeutics Holdings, Inc. →
Sell to companies like Sonnet BioTherapeutics Holdings, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2024-12-23 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Sonnet BioTherapeutics Holdings, Inc.
Free to see. No signup.
More on the people and the money behind Sonnet BioTherapeutics Holdings, Inc., from the filings we hold.
Biotechnology raises by companies based in New Jersey, filed within 90 days of this one, largest first.
Get an email when Sonnet BioTherapeutics Holdings, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Sonnet BioTherapeutics Holdings, Inc. raises, hires or launches. No email unless you switch it on.
Watch Sonnet BioTherapeutics Holdings, Inc. →Get the full cited report on Sonnet BioTherapeutics Holdings, Inc.
What the filing shows about Sonnet BioTherapeutics Holdings, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Sonnet BioTherapeutics Holdings, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Sonnet BioTherapeutics Holdings, Inc.'s address as 100 Overlook Cetner, Suite 102, Princeton, NJ 08540.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Sonnet BioTherapeutics Holdings, Inc. See pricing
Sonnet BioTherapeutics Holdings, Inc. is a registered filer with the SEC (CIK 1106838) and has filed since 2023-07-17. 2 filings are on record, the latest on 2024-12-23.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Sonnet BioTherapeutics Holdings, Inc.'s Form D of 2024-12-23 names Pankaj Mohan, Jay Cross, John Cini and 7 more as its officers, directors or promoters.
Its new offerings report $6.17M sold across 2 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 763 filings in Biotechnology, totalled by week.
The Company intends to use the net proceeds for research and development, including clinical trials, working capital and general corporate purposes.
Pankaj Mohan is named as Executive Officer and Director on the Form D that Sonnet BioTherapeutics Holdings, Inc. filed with the SEC on 23 December 2024, one of 10 people that filing names.
Jay Cross is named as Executive Officer on the Form D that Sonnet BioTherapeutics Holdings, Inc. filed with the SEC on 23 December 2024, one of 10 people that filing names.
John Cini is named as Executive Officer on the Form D that Sonnet BioTherapeutics Holdings, Inc. filed with the SEC on 23 December 2024, one of 10 people that filing names.
Susan Dexter is named as Executive Officer on the Form D that Sonnet BioTherapeutics Holdings, Inc. filed with the SEC on 23 December 2024, one of 10 people that filing names.
Richard Kenny is named as Executive Officer on the Form D that Sonnet BioTherapeutics Holdings, Inc. filed with the SEC on 23 December 2024, one of 10 people that filing names.
Nailesh Bhatt is named as Director on the Form D that Sonnet BioTherapeutics Holdings, Inc. filed with the SEC on 23 December 2024, one of 10 people that filing names.
Albert Dyrness is named as Director on the Form D that Sonnet BioTherapeutics Holdings, Inc. filed with the SEC on 23 December 2024, one of 10 people that filing names.
Donald Griffith is named as Director on the Form D that Sonnet BioTherapeutics Holdings, Inc. filed with the SEC on 23 December 2024, one of 10 people that filing names.
Raghu Rao is named as Director on the Form D that Sonnet BioTherapeutics Holdings, Inc. filed with the SEC on 23 December 2024, one of 10 people that filing names.
Lori McNeil is named as Director on the Form D that Sonnet BioTherapeutics Holdings, Inc. filed with the SEC on 23 December 2024, one of 10 people that filing names.
10 people named on the filing — 5 holding an executive role and 5 as directors only.
Named as of the 2024-12-23 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Sonnet BioTherapeutics Holdings, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Sonnet BioTherapeutics Holdings, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Sonnet BioTherapeutics Holdings, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Sonnet BioTherapeutics Holdings, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Sonnet BioTherapeutics Holdings, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Sonnet BioTherapeutics Holdings, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in Northern New Jersey
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/sonnet-biotherapeutics-holdings-inc-form-d-24000001